Syncom Formulations: Trading Window Closed Oct 1 for Q2 FY27 Results
Syncom Formulations will close its trading window from October 1, 2026, until 48 hours after announcing its Q2 FY27 unaudited financial results. This measure complies with SEBI insider trading regulations, restricting trading by insiders during the closure period.
The closure of the trading window is a standard compliance procedure and does not directly impact the company's operations or financial performance. It is a routine disclosure.
The announcement is a routine regulatory disclosure regarding the closure of the trading window, which is standard practice before financial results are announced. It does not contain any information that positively or negatively impacts the company's performance or outlook.
Syncom Formulations (India) Limited has announced the closure of its trading window for dealing in the company's securities. The window will be shut from October 1, 2026, and will remain closed until 48 hours after the declaration of the Unaudited Standalone & Consolidated Financial Results for the quarter and half year ended September 30, 2026.
This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and related circulars. All promoters, directors, key managerial personnel (KMPs), designated persons, employees, connected persons, fiduciaries, and their immediate relatives are advised not to trade in the company's shares during this period.
The date for the Board of Directors' meeting to approve these financial results will be intimated in due course. The company will also file the required disclosures in XBRL format and host them on its website.
What to do with a filing like this
Syncom Formulations (India) Limited filed this with the NSE as a statutory disclosure, categorised under trading window disclosure. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Syncom Formulations (India) Limited. Read the original for the full detail.